Clinical Trial: LC-Plasma on Immune Response and Reducing Symptoms of Upper Respiratory Infectious Diseases
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Healthy Volunteer
Study Type: INTERVENTIONAL
Official Title: The Effects of Lactococcus Lactis JCM 5805 (LC-Plasma) Lactic Acid Bacteria on Immune Response and Reducing Symptoms of Upper Respiratory Infectious Disease in Australian Healthy Adults. Randomized Pl
Brief Summary:
The goal of this study is to evaluate the effects of LC-Plasma on the innate and acquired immune systems, including the activation of pDCs, which play a role in virus elimination, as well as to assess its efficacy in reducing clinical symptoms of upper respiratory infectious diseases in healthy adults.Researchers will compare LC-Plasma to placebo, participants will take a tablet containing LC-Plasma or placebo daily for 4 weeks.
Read more